Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Oligopeptide-targeted polymer nanoprobes for fluorescence-guided endoscopic surgery

R Pola, J Parnica, K Zuska, E Böhmová, M Filipová, M Pechar, J Pankrác, J Mucksová, J Kalina, P Trefil, L Šefc, D Větvička, P Poučková, J Bouček, O Janoušková and T Etrych

. 2019 ; 2 (2) : 024004.

Status minimální Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22008065

Grantová podpora
NV16-28594A MZ0 CEP - Centrální evidence projektů

A polymer probe based on N-(2-hydroxypropyl)methacrylamide copolymers labelled with a fluorescent dye Dy-633 or Cy-7 and decorated with targeting oligopeptides GE-7 or GE-11, specific targeting ligands binding to epidermal growth factor receptor (EGFR) highly expressed on surface of tumour cells, was designed, synthesised and characterised. Specific accumulation of the polymer probe in the tumour mass is a prerequisite for successful fluorescence-guided endoscopic surgery as the fluorescence signal from the malignant cells enables more precise resection of the tumour without damaging the healthy tissue. Flow cytometry and confocal microscopy was used to assess the binding efficacy of the oligopeptide conjugates to EGFR on the cell membranes of the malignant cells. The results showed that the highest binding efficacy was achieved with polymers bearing the GE-11 targeting oligopeptide in human EGFR-positive hypopharyngeal carcinoma cells (FaDu) and in breast adenocarcinoma cells (MDA-MB-231). Similarly, the polymer probes targeted by the GE-11 oligopeptidewere found in vivo as highly effective in tumour accumulation, as determined from fluorescence imaging. Indeed, the ex vivo cross-section of the tumours showed significant tumour border fluorescence proving the potential of the studied polymer probes. Moreover, the presence of the active targeting moiety on the polymer-drug conjugate should enable the use of such a conjugate as a targeted polymer system for treatment of solid tumours. Replacement of the fluorescent probe with a cytostatic drug provides a targeted polymer nanocancerostatic for advanced treatment of neoplastic diseases, thus the polymer probes have multiple functions.

000      
00000naa a2200000 a 4500
001      
bmc22008065
003      
CZ-PrNML
005      
20220311180818.0
007      
ta
008      
220311s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1088/2399-7532/ab159e $2 doi
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pola, Robert $7 xx0232782 $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
245    10
$a Oligopeptide-targeted polymer nanoprobes for fluorescence-guided endoscopic surgery / $c R Pola, J Parnica, K Zuska, E Böhmová, M Filipová, M Pechar, J Pankrác, J Mucksová, J Kalina, P Trefil, L Šefc, D Větvička, P Poučková, J Bouček, O Janoušková and T Etrych
520    9_
$a A polymer probe based on N-(2-hydroxypropyl)methacrylamide copolymers labelled with a fluorescent dye Dy-633 or Cy-7 and decorated with targeting oligopeptides GE-7 or GE-11, specific targeting ligands binding to epidermal growth factor receptor (EGFR) highly expressed on surface of tumour cells, was designed, synthesised and characterised. Specific accumulation of the polymer probe in the tumour mass is a prerequisite for successful fluorescence-guided endoscopic surgery as the fluorescence signal from the malignant cells enables more precise resection of the tumour without damaging the healthy tissue. Flow cytometry and confocal microscopy was used to assess the binding efficacy of the oligopeptide conjugates to EGFR on the cell membranes of the malignant cells. The results showed that the highest binding efficacy was achieved with polymers bearing the GE-11 targeting oligopeptide in human EGFR-positive hypopharyngeal carcinoma cells (FaDu) and in breast adenocarcinoma cells (MDA-MB-231). Similarly, the polymer probes targeted by the GE-11 oligopeptidewere found in vivo as highly effective in tumour accumulation, as determined from fluorescence imaging. Indeed, the ex vivo cross-section of the tumours showed significant tumour border fluorescence proving the potential of the studied polymer probes. Moreover, the presence of the active targeting moiety on the polymer-drug conjugate should enable the use of such a conjugate as a targeted polymer system for treatment of solid tumours. Replacement of the fluorescent probe with a cytostatic drug provides a targeted polymer nanocancerostatic for advanced treatment of neoplastic diseases, thus the polymer probes have multiple functions.
700    1_
$a Parnica, J $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
700    1_
$a Zuska, K $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
700    1_
$a Böhmová, Eliška $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz) $7 xx0232781
700    1_
$a Filipová, M $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
700    1_
$a Pechar, Michal, $d 1967- $u First Faculty of Medicine, Charles University Prague, U Nemocnice 5, 120 00, Prague 2, Czechia $7 xx0141621
700    1_
$a Pankrác, J $u First Faculty of Medicine, Charles University Prague, U Nemocnice 5, 120 00, Prague 2, Czechia
700    1_
$a Mucksová, J $u BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s., 254 49 Jilove u Prahy, Czechia
700    1_
$a Kalina, J $u BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s., 254 49 Jilove u Prahy, Czechia
700    1_
$a Trefil, P $u BIOPHARM, Research Institute of Biopharmacy and Veterinary Drugs, a.s., 254 49 Jilove u Prahy, Czechia
700    1_
$a Šefc, Luděk, $d 1960- $u First Faculty of Medicine, Charles University Prague, U Nemocnice 5, 120 00, Prague 2, Czechia $7 xx0092587
700    1_
$a Větvička, David $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovská 1, 120 00, Prague 2, Czechia $7 xx0214483
700    1_
$a Poučková, Pavla, $d 1950- $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovská 1, 120 00, Prague 2, Czechia $7 jo2002102951
700    1_
$a Bouček, Jan, $d 1976- $u Department of Otorhinolaryngology Head and Neck Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague 5, Czechia $7 xx0100852
700    1_
$a Janoušková, O $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
700    1_
$a Etrych, T $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 162 06 Prague 6, Czechia (www.imc.cas.cz)
773    0_
$t Multifunctional Materials $x 2399-7532 $g Roč. 2, č. 2 (2019), s. 024004 $w boh
910    __
$a ABA008 $y 0 $z 0
990    __
$a 20220311180810 $b ABA008
991    __
$a 20220311180810 $b ABA008
999    __
$a min $b bmc $g 1769015 $s 1159259
BAS    __
$a 3
BMC    __
$a 2019 $b 2 $c 2 $d 024004 $x boh $i 2399-7532 $m Multifunctional Materials
GRA    __
$a NV16-28594A $p MZ0

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...